Related references
Note: Only part of the references are listed.Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease
J. Torres et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis
John E. Eaton et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Colon Neoplasms Develop Early in the Course of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
Erin W. Thackeray et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
AGA Medical Position Statement on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease
Francis A. Farraye et al.
GASTROENTEROLOGY (2010)
Bile Acid Changes After High-Dose Ursodeoxycholic Acid Treatment in Primary Sclerosing Cholangitis: Relation to Disease Progression
Emmanouil Sinakos et al.
HEPATOLOGY (2010)
Outcome After Surveillance of Low-grade and Indefinite Dysplasia in Patients with Ulcerative Colitis
Joel R. Pekow et al.
INFLAMMATORY BOWEL DISEASES (2010)
High-Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis
Keith D. Lindor et al.
HEPATOLOGY (2009)
More Right-sided IBD-associated Colorectal Cancer in Patients with Primary Sclerosing Cholangitis
M. M. H. Claessen et al.
INFLAMMATORY BOWEL DISEASES (2009)
European evidence-based Consensus on the management of ulcerative colitis: Special situations
Livia Biancone et al.
JOURNAL OF CROHNS & COLITIS (2008)
Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis
Harry Sokol et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis
JM Wolf et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
High-dose ursodeoxycholic acid in primary sclerosing cholangitis:: A 5-year multicenter, randomized, controlled study
R Olsson et al.
GASTROENTEROLOGY (2005)
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence
DS Alberts et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
EV Loftus et al.
GUT (2005)
Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: An observational study
L Serfaty et al.
HEPATOLOGY (2003)
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
DS Pardi et al.
GASTROENTEROLOGY (2003)
Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis
RM Soetikno et al.
GASTROINTESTINAL ENDOSCOPY (2002)
Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis
BY Tung et al.
ANNALS OF INTERNAL MEDICINE (2001)
Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine - Results from a 20-year surveillance study
BU Lindberg et al.
DISEASES OF THE COLON & RECTUM (2001)
Share Paper
